BSEResonance Specialties Ltd-$· Chemicals & PetrochemicalsHighNeutral
Announced Wed, 4 Feb, 2026 · 13:48 IST

UNAUDITED RESULTS FOR Q3 AND 9 MONTHS ENDED DECEMBER 31, 2025

Revenue Growth 20pctPat Growth 25pctEbitda Margin ExpansionExceptional ItemResults View source PDFExplain this filing

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close
+1.9%Reaction day
₹112.85
prior close
₹112.00
announcement price
In-mkt
timing
Nifty Microcap 250market · in no size index; the smallest one is used+1.3%+0.6% vs market
Specialty Chemicals peers, median of 86sector+0.3%+1.6% vs sector

On the reaction day the stock moved 0.6 pts more than Nifty Microcap 250 and 1.6 pts more than its Specialty Chemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark
Stock
5m
+5.2
10m
+4.5
15m
+5.4
30m
+2.5
Sessions after the filingfrom the prior close
StockMarketvs marketSectorvs sector
Reaction day
+1.9+1.3+0.6+0.3+1.6
Next day
-4.0+0.3-4.3-0.0-4.0
2d
-3.7-0.5-3.2-0.8-2.9
3d
-3.4+2.1-5.5+1.6-5.0
4d
-4.3+3.1-7.4+2.0-6.3
5d
-6.4+2.6-9.0+2.1-8.5
1w
-13.0+0.6-13.6-0.1-12.9
15d
-11.8-1.4-10.4-3.6-8.2
1m
-15.8-6.9-8.9-9.0-6.8
2m
-24.3-7.7-16.6-9.2-15.1
3m
-10.5+7.0-17.5+2.9-13.4
UpDownMarket · Nifty Microcap 250Sector · Specialty Chemicals peers, median of 86Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Resonance Specialties reported strong Q3 FY26 results with revenue from operations rising about 26% year-on-year to Rs. 2,296.27 lakhs (vs Rs. 1,823.82 lakhs in Q3 FY25). For the nine months ended December 2025, revenue grew roughly 23% to Rs. 6,577.04 lakhs versus Rs. 5,360.49 lakhs a year earlier. Profit after tax surged to Rs. 251.28 lakhs in Q3 (vs Rs. 111.55 lakhs) and to Rs. 580.02 lakhs for nine months (vs Rs. 350.87 lakhs, which had included a Rs. 77.34 lakh exceptional item). Basic EPS stood at Rs. 2.18 for the quarter and Rs. 5.02 for nine months. The Board also appointed Ms. Dhara Shah as Independent Director for five years, elevated Mr. Raj Kamal Prasad Verma as the new Chairman (replacing Mrs. Archana Yadav who completes her second term), and reconstituted all key board committees. The statutory auditor (Kailash Chand Jain & Co.) issued a clean limited review report with no qualifications.

Likely market impact

Sharp revenue growth, expanding margins, and a sharp jump in profit signal strong operational momentum, likely a positive catalyst for the stock in the near term. The Board refresh with a new Independent Director and Chairman improves governance continuity.